These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 1687944)

  • 1. Locomotor hyperactivity induced by MK-801 in rats.
    Maj J; Rogóz Z; Skuza G
    Pol J Pharmacol Pharm; 1991; 43(6):449-58. PubMed ID: 1687944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central effects of SL 82.0715, an antagonist of polyamine site of the NMDA receptor complex.
    Dereń-Wesołek A; Maj J
    Pol J Pharmacol; 1993; 45(5-6):467-80. PubMed ID: 7912135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haloperidol and MK-801 block increases in striatal calmodulin resulting from repeated amphetamine treatment.
    Gnegy ME; Hewlett GH; Pimputkar G
    Brain Res; 1996 Sep; 734(1-2):35-42. PubMed ID: 8896805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central effects of CGP 37849 and CGP 39551, competitive NMDA receptor antagonists, in mice.
    Maj J; Rogóz Z; Skuza G
    Pol J Pharmacol; 1993; 45(4):349-60. PubMed ID: 7906989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of combined treatment with MK-801 and antidepressant drugs in the forced swimming test in rats.
    Maj J; Rogóz Z; Skuza G
    Pol J Pharmacol Pharm; 1992; 44(3):217-26. PubMed ID: 1470560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for involvement of brain dopamine and other mechanisms in the behavioral action of the N-methyl-D-aspartic acid antagonist MK-801 in control and 6-hydroxydopamine-lesioned rats.
    Criswell HE; Johnson KB; Mueller RA; Breese GR
    J Pharmacol Exp Ther; 1993 May; 265(2):1001-10. PubMed ID: 8098756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopaminergic basis for the facilitation of brain stimulation reward by the NMDA receptor antagonist, MK-801.
    Olds ME
    Eur J Pharmacol; 1996 Jun; 306(1-3):23-32. PubMed ID: 8813611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Some behavioral effects of 1,3-di-o-tolylguanidine, opipramol and sertraline, the sigma site ligands.
    Maj J; Rogóz Z; Skuza G
    Pol J Pharmacol; 1996; 48(4):379-95. PubMed ID: 9112678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antidepressant drugs increase the locomotor hyperactivity induced by MK-801 in rats.
    Maj J; Rogóz Z; Skuza G
    J Neural Transm Gen Sect; 1991; 85(3):169-79. PubMed ID: 1930880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relative importance of dopamine and noradrenaline receptor stimulation for the restoration of motor activity in reserpine or alpha-methyl-p-tyrosine pre-treated mice.
    Dolphin AC; Jenner P; Marsden CD
    Pharmacol Biochem Behav; 1976 Jun; 4(6):661-70. PubMed ID: 981283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The central action of carbamazepine as a potential antidepressant drug.
    Maj J; Chojnacka-Wójcik E; Lewandowska A; Tatarczyńska E; Wiczyńska B
    Pol J Pharmacol Pharm; 1985; 37(1):47-56. PubMed ID: 4041037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Locomotor activation induced by MK-801 in the rat: postsynaptic interactions with dopamine receptors in the ventral striatum.
    Ouagazzal A; Nieoullon A; Amalric M
    Eur J Pharmacol; 1994 Jan; 251(2-3):229-36. PubMed ID: 8149978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modification by MK-801 (dizocilpine), a noncompetitive NMDA receptor antagonist, of morphine sensitization: evaluation by ambulation in mice.
    Iijima Y; Asami T; Kuribara H
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1996 Feb; 16(1):11-8. PubMed ID: 8640458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pentadecapeptide BPC 157 counteracts L-NAME-induced catalepsy. BPC 157, L-NAME, L-arginine, NO-relation, in the suited rat acute and chronic models resembling 'positive-like' symptoms of schizophrenia.
    Zemba Cilic A; Zemba M; Cilic M; Balenovic I; Strbe S; Ilic S; Vukojevic J; Zoricic Z; Filipcic I; Kokot A; Drmic D; Blagaic AB; Tvrdeic A; Seiwerth S; Sikiric P
    Behav Brain Res; 2021 Jan; 396():112919. PubMed ID: 32956773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The synergistic effect of fluoxetine on the locomotor hyperactivity induced by MK-801, a non-competitive NMDA receptor antagonist.
    Maj J; Rogóz Z; Skuza G; Wedzony K
    J Neural Transm (Vienna); 1996; 103(1-2):131-46. PubMed ID: 9026367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of intraventricular dopamine on the spontaneous locomotor activity of rats pretreated with nialamide, reserpine, or alpha-methyl-p-tyrosine.
    Malec D; Kleinrok Z
    Pol J Pharmacol Pharm; 1973; 25(4):357-66. PubMed ID: 4774244
    [No Abstract]   [Full Text] [Related]  

  • 17. Dopamine agonist-induced locomotor activity in rats treated with 6-hydroxydopamine at differing ages: functional supersensitivity of D-1 dopamine receptors in neonatally lesioned rats.
    Breese GR; Napier TC; Mueller RA
    J Pharmacol Exp Ther; 1985 Aug; 234(2):447-55. PubMed ID: 3926987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of MK-801 and antidepressant drugs in the forced swimming test in rats.
    Maj J; Rogóz Z; Skuza G; Sowińska H
    Eur Neuropsychopharmacol; 1992 Mar; 2(1):37-41. PubMed ID: 1638172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trace amines inhibit the electrically evoked release of [3H]acetylcholine from slices of rat striatum in the presence of pargyline: similarities between beta-phenylethylamine and amphetamine.
    Baud P; Arbilla S; Cantrill RC; Scatton B; Langer SZ
    J Pharmacol Exp Ther; 1985 Oct; 235(1):220-9. PubMed ID: 3930699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional alteration by NMDA antagonist: effects of L-Dopa, neuroleptics drug and postnatal administration.
    Fredriksson A; Archer T
    Amino Acids; 2002; 23(1-3):111-32. PubMed ID: 12373526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.